Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-05-17
2011-05-17
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100
Reexamination Certificate
active
07943152
ABSTRACT:
Chalazia and hordeola are the most common lesions occurring in the human eyelid, and often recurrences are managed by surgical intervention to remove fatty inclusions within the lid with associated inflammatory reaction. The present invention provides non-surgical methods of treating chalazia, hordeola and cutaneous infections comprising the administration of compositions comprising botulinum toxin. The present invention provides methods that effectively block meibum secretion from the meibomian glands, reduce sebaceous bacterial culture media on skin, and sebaceous secretion from the glands of Zeis. Decreased production of meibum and associated fatty substances resulting from the methods of the present invention, decrease gland blockage and tissue inspissations, resulting in reduced recurrence of chalazia, hordeola and related inflammatory reactions and lesions.
REFERENCES:
patent: 5401243 (1995-03-01), Borodic
patent: 5670484 (1997-09-01), Binder
patent: 5766605 (1998-06-01), Sanders et al.
patent: 6063768 (2000-05-01), First
patent: 6299893 (2001-10-01), Schwartz et al.
patent: 6358926 (2002-03-01), Donovan
patent: 6429189 (2002-08-01), Borodic
patent: 6632440 (2003-10-01), Quinn et al.
patent: 7226605 (2007-06-01), Suskind et al.
patent: 7255865 (2007-08-01), Walker
patent: 7288259 (2007-10-01), Sanders et al.
patent: 7335367 (2008-02-01), Borodic
patent: 7691394 (2010-04-01), Borodic
patent: 2002/0082197 (2002-06-01), Aoki et al.
patent: 2002/0107199 (2002-08-01), Walker
patent: 2003/0113349 (2003-06-01), Coleman, III
patent: 2003/0157134 (2003-08-01), Aoki et al.
patent: 2003/0180289 (2003-09-01), Foster et al.
patent: 2004/0013692 (2004-01-01), Aoki et al.
patent: 2004/0170665 (2004-09-01), Donovan
patent: 2004/0226556 (2004-11-01), Deem et al.
patent: 2004/0247606 (2004-12-01), Borodic et al.
patent: 2004/0248188 (2004-12-01), Sanders
patent: 2005/0058666 (2005-03-01), Aoki et al.
patent: 2005/0129716 (2005-06-01), Aoki et al.
patent: 2005/0142105 (2005-06-01), Puri
patent: 2005/0147626 (2005-07-01), Blumenfeld
patent: 2005/0220820 (2005-10-01), Sanders et al.
patent: 1 005 867 (2000-06-01), None
patent: 1 005 867 (2001-06-01), None
patent: 95/28171 (1995-10-01), None
patent: 99/03483 (1999-01-01), None
patent: 02/00172 (2002-01-01), None
patent: 02/000172 (2002-01-01), None
patent: 03/011333 (2003-02-01), None
patent: 03/026602 (2003-04-01), None
patent: 03/026602 (2003-08-01), None
patent: 2004/016763 (2004-02-01), None
patent: 2004/016763 (2004-02-01), None
patent: 2004/016763 (2004-06-01), None
De Almeida, HL Jr. et al, International Journal of Dermatology, vol. 39, pp. 698-700, 2000.
Heckmann, M et al, The New England Journal of Medicine, vol. 344(7), pp. 488-493, Feb. 15, 2001.
Mauriello, JA Jr. et al, Br. J. Ophthalmol., Dec. 1996, vol. 80 12, pp. 1073-1076.
Moguel-Ancheita, S et al, Arch. Soc. Esp. Oftalmol. 2003, vol. 78, pp. 9-14.
O'Day, J, Curr. Opin. Ophthalmol. Dec. 2001, vol. 12(6), pp. 419-422, Use of botulinum toxin in neuro-ophthalmology.
Sahlin, S et al, Am. J. Ophthalmol., Apr. 2000, vol. 129(4), pp. 481-486.
Uddin, JM et al, Ophthalmology, Jun. 2002, vol. 109(6), pp. 1183-1187.
Verheyden, J et al, Seminars in Cutaneous Medicine and Surgery, vol. 20(2), June, pp. 121-126.
Borodic et al “Botulinum toxin for the treatment of pain and inflammatory disorders,” Expert Opin Investig 10(8) 1531-1544, 2001.
Carter, Susan R., Eyelid Disorders: Diagnosis and Management, XP-002286815.
U.S. Appl. No. 60/404,378, which is the priority application for Sander's PCT/US03/25708 and US 7,288,259.
Botulinum Toxin Research Associates, Inc.
Milbank Tweed Hadley & McCloy LLP
Navarro Mark
Portner Ginny
LandOfFree
Treatment of chronic chalazion and hordeolum with botulinum... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of chronic chalazion and hordeolum with botulinum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of chronic chalazion and hordeolum with botulinum... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666379